RACS

Positive Interim Data of BellaSeno's Clinical Trial with Resorbable Breast and Chest Implants Reported at RACS 2023

Retrieved on: 
Tuesday, May 9, 2023

The results were presented at the 91st Annual Scientific Congress 2023 of the Royal Australasian College of Surgeons (RACS) .

Key Points: 
  • The results were presented at the 91st Annual Scientific Congress 2023 of the Royal Australasian College of Surgeons (RACS) .
  • Michael Wagels, Principal Investigator of the first clinical trial evaluating BellaSeno's implant with autologous fat grafting for pectus excavatum camouflage, reported 3-year data from the first in-human case.
  • Not only was the implant safe and well tolerated, but histologic studies demonstrated tissue growth and vascularization within the implant scaffold.
  • Wagels also presented animal data from large 450 ccm scaffolds showing that tissue was fully regenerated in this large volume without the development of necrosis.

Like GPS, But For the Cleanest Route: BreezoMeter’s Newest Offering Bets Big on Clean Air

Retrieved on: 
Thursday, September 8, 2022

Drivers are exposed to larger concentrations of pollutants inside their vehicles than those traveling by bike or on foot, according to research conducted by the University of Leicester. A vehicle’s in-cabin air quality can be impacted by a number of external factors, including pollutants in outside air, traffic, and vehicle speed. The air quality in traffic is especially toxic considering the presence of the pollutant PM2.5--particulate matter that is small enough to enter people’s respiratory systems unnoticed, posing serious short-term and long-term health risks. As awareness of their exposure to toxins grows, drivers are more likely to opt to travel to their destination on the route that is the cleanest.

Key Points: 
  • A vehicles in-cabin air quality can be impacted by a number of external factors, including pollutants in outside air, traffic, and vehicle speed.
  • Using BreezoMeters Cleanest Route, companies can provide users and consumers with navigation recommendations based on BreezoMeters environmental data to avoid the day-to-day impacts of poor air quality on their health and wellbeing.
  • And companies like Cowboy and AllTrails recommend the cleanest routes to cyclists, hikers, and runners based on BreezoMeters air quality data via their mobile apps.
  • The result is street-level air quality resolution (within 5 meters), and pollen, pollutants and fire data, in more than 100 countries.

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

Retrieved on: 
Thursday, July 14, 2022

EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (Zymergen or the Company) today announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines.

Key Points: 
  • EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (Zymergen or the Company) today announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines.
  • In May, Octant purchased five Reconfigurable Automation Carts, or RACs, to improve the throughput, efficiency, and reliability of operations for its existing platform.
  • Its been an incredible journey to watch this technology develop internally at Zymergen and even more rewarding to now see it outside of Zymergen, supporting other companies missions.
  • Octant is a next-generation therapeutics company integrating novel and scaled experimental technologies (multiplexed measurements and high-throughput synthetic chemistry) with computation to solve complex challenges in drug discovery.

Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

Retrieved on: 
Thursday, May 26, 2022

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (Zymergen or the Company), today announced it has entered into an agreement with Octant for the sale of a modular automation system to scale Octants next-generation platform to develop breakthrough medicines.

Key Points: 
  • EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (Zymergen or the Company), today announced it has entered into an agreement with Octant for the sale of a modular automation system to scale Octants next-generation platform to develop breakthrough medicines.
  • Zymergens complete automation solution includes modular hardware, modern web-based software, custom and turnkey workflows, and active monitoring and support.
  • Octant is a leading therapeutics company focused on developing drugs that match the complexity of human disease, said Sri Kosuri, Co-founder and Chief Executive Officer of Octant.
  • The initial installation consists of 5 Reconfigurable Automation Carts with plans to expand over time as Octant scales their workflows.

Keysight First to Gain PTCRB Validation Group (PVG) Acceptance for 5G New Radio Release 16 Test Cases

Retrieved on: 
Friday, May 13, 2022

The approval was made using Keysights S8704A Protocol Conformance Toolset at a PTCRB validation group (PVG) meeting held from May 10 to 12, 2022.

Key Points: 
  • The approval was made using Keysights S8704A Protocol Conformance Toolset at a PTCRB validation group (PVG) meeting held from May 10 to 12, 2022.
  • Rel-16 delivers a wide range of enhancements over Rel-15, including improvements in 5G network coverage, capacity, security and latency, as well as 5G device power consumption, mobility and reliability.
  • These early test cases provided by Keysight enable vendors to accelerate the verification of designs that support the realization of smart city, smart factory and autonomous vehicles.
  • Keysight delivers advanced design and validation solutions that help accelerate innovation to connect and secure the world.

2022 GBK Brand Bar Made a Roaring Comeback to Celebrate the 94th Academy Awards with their Ultra-Exclusive Pre-Oscar Lounge at the Beverly Wilshire Hotel: "The eBay & GBK Brand Bar Pre-Oscar Luxury Lounge!"

Retrieved on: 
Monday, March 28, 2022

LOS ANGELES, March 28, 2022 /PRNewswire/ -- Since its inception, GBK Brand Bar has always been the most exclusive celebrity lounge for major awards shows. With the sudden stop of all events during the pandemic, GBK quickly pivoted, closing GBK Productions, and launching a new concept store, GBK Brand Bar at the chic Kimpton La Peer Hotel run by GM, Nick Remedio.  This brick and mortar provided a lifeline to brands and the opportunity to showcase their products as well as gain a greater audience despite the pause on gift lounges. 

Key Points: 
  • GBK CEO, Gavin Keilly, welcomed nominees not only from the Oscars, but SAG, Golden Globes and GRAMMY Awards since this is their first lounge of the year.
  • LOS ANGELES, March 28, 2022 /PRNewswire/ --Since its inception, GBK Brand Bar has always been the most exclusivecelebrity lounge for major awards shows.
  • Celebrities gather ahead of the Academy Awards for the eBay & GBK Brand Bar Pre-Oscar Luxury Lounge
    Now, GBK Brand Bar has come back to lead the way again with their Pre-Oscar Lounge at the Beverly Wilshire Hotel.
  • The title sponsor of this year's lounge was eBay, who gifted luxury handbags and watches to attendees.

TOMI Obtains EPA Registration of SteraMist® BIT™ 0.35% for Agricultural and Food Safety Use

Retrieved on: 
Monday, October 11, 2021

This is the companys third EPA registration and significantly expands Companys addressable markets.

Key Points: 
  • This is the companys third EPA registration and significantly expands Companys addressable markets.
  • The company previous registrations are SteraMist, 90150-1 for mold and mildew and 90150-2 for Hospital-Healthcare facilities.
  • SteraMist BIT0.35% is a low-percentage solution designed for agricultural applications, as well as sites requiring more precise application of ionized Hydrogen Peroxide (iHP).
  • This EPA registration comes after years of research, expansive testing with SteraMist technology, as well as cooperating with the lengthy EPA registration processes during the pandemic.